Sri Lanka is seeing angry protesters out on the streets, after being hit by hours-long power cuts and a shortage of essentials like fuel, medicine and other items. Here’s what went wrong for the island nation

Chinese stocks suffered their biggest fall in a month as Covid restrictions and inflation worries weighed heavily on investors

Presi­dent Joe Biden will talk to Indian leader Narendra Modi on Monday, at a time when the US has made clear it does not want to see a big uptick in Russian energy imports by India

Chinese oil giant CNOOC said on Monday it will raise 28.08 billion yuan ($4.4 billion) in a listing in Shanghai, after setting the price for what will be the mainland 11th-biggest public stock offering

Taiwan's Evergreen Marine has purchased 44 vessels from China since 2018, all but two of which were ordered from shipyards that produce Chinese warships

If new technologies work, they will help boost lithium production with a footprint smaller than open-pit mines and evaporation ponds, which often are the size of multiple football fields

Supply-chain disruptions, rocketing inputs costs, and the partial removal of government subsidies for China EV manufacturers have driven a stock market selloff

Russia is turning to microchip manufacturers in China to circumvent western sanctions which have boosted demand for bank cards linked to Mir payment system, a payment card executive said.

Hozon startled industry watchers by growing sales of its affordable SUVs more than fourfold in the first two months of...

Huawei paid out dividends totalling 61.4 billion yuan ($9.65 billion) to current and retired workers in its employee shareholder scheme, a filing with the Shanghai Clearing House shows

Poll comes after Tesla CEO disclosed a 9.2% stake in Twitter earlier in the day, worth nearly $3 billion, that made him the micro-blogging site's largest shareholder

Chinese vaccine developer CanSino Biologics said on Monday its potential Covid-19 vaccine using mRNA technology has been approved by the medical products regulator to enter clinical trials